{"name":"Lisata Therapeutics, Inc.","slug":"lisata-therapeutics-inc","ticker":"","exchange":"","domain":"","description":"","hq":"","founded":0,"employees":"","ceo":"","sector":"","stockPrice":0,"stockChange":0,"stockChangePercent":0,"marketCap":"","metrics":{"revenue":0,"revenueGrowth":0,"grossMargin":0,"rdSpend":0,"netIncome":0,"cash":0,"dividendYield":0,"peRatio":0,"fiscalYear":"FY2026"},"revenueBreakdown":[],"timeline":[{"date":"2026-07-28","label":"Q2 2026 Earnings","type":"earnings","sentiment":"neutral"},{"date":"2026-10-28","label":"Q3 2026 Earnings","type":"earnings","sentiment":"neutral"},{"date":"2027-01-28","label":"Q4 2027 Earnings","type":"earnings","sentiment":"neutral"},{"date":"2027-04-28","label":"Q1 2027 Earnings","type":"earnings","sentiment":"neutral"},{"date":"2027-07-28","label":"Q2 2027 Earnings","type":"earnings","sentiment":"neutral"},{"date":"2027-10-28","label":"Q3 2027 Earnings","type":"earnings","sentiment":"neutral"}],"diseaseAreas":[{"name":"Cardiovascular","slug":"cardiovascular","revenue":0,"percentOfTotal":0,"drugCount":2,"colorKey":"immunology","drugs":[{"name":"CLBS03 High Dose","genericName":"CLBS03 High Dose","slug":"clbs03-high-dose","indication":"Ischemic heart failure","status":"phase_2"},{"name":"CLBS12","genericName":"CLBS12","slug":"clbs12","indication":"Treatment of heart failure","status":"phase_2"}]},{"name":"Other","slug":"other","revenue":0,"percentOfTotal":0,"drugCount":1,"colorKey":"oncology","drugs":[{"name":"Auto-CD34+ cells","genericName":"Auto-CD34+ cells","slug":"auto-cd34-cells","indication":"Critical limb ischemia","status":"phase_3"}]}],"pipeline":[{"name":"Auto-CD34+ cells","genericName":"Auto-CD34+ cells","slug":"auto-cd34-cells","phase":"phase_3","mechanism":"Auto-CD34+ cells are autologous CD34+ hematopoietic stem cells mobilized and collected from a patient's own bone marrow or peripheral blood, then reinfused to promote tissue regeneration and repair.","indications":["Critical limb ischemia","Severe peripheral artery disease"],"catalyst":""},{"name":"CLBS03 High Dose","genericName":"CLBS03 High Dose","slug":"clbs03-high-dose","phase":"phase_2","mechanism":"CLBS03 High Dose is a cell therapy that aims to repair or replace damaged heart tissue.","indications":["Ischemic heart failure"],"catalyst":""},{"name":"CLBS12","genericName":"CLBS12","slug":"clbs12","phase":"phase_2","mechanism":"CLBS12 is a cell therapy product that aims to repair or replace damaged heart tissue.","indications":["Treatment of heart failure"],"catalyst":""}],"recentEvents":[],"realNews":[{"url":"https://news.google.com/rss/articles/CBMi8gFBVV95cUxOMTF2SVFwaGtHS2ZZdS14RTQ2cTFpcHo3YWdIR1BfOTlaVTVuTDhYdFp0QklTUVlHR2dYRmd2dnNhaWlyUDJlekNnTU90WjE1a3RKRDdPVUhjQlJTMUVrd2F6YXlxNXBHM1RydVkwSkxNdlJ3NWFUVzlwZmFLaTZLVVI5Y2p6dmRQUmxDUl9NWEp6T09DREV5R1lLTlRMRlp5Q3RIM0FXdU9MYXo5YXZYMWhSa1J1U2Y2U01ha0s2cGNSTlhsWk52VjhHSmd5NDgyYmlqS0E5YVcyREdrYV93U0h2RkR2MnBaM2I0VzBFSGNQUQ?oc=5","date":"2026-03-06","type":"deal","source":"GlobeNewswire","summary":"Lisata Therapeutics Enters into Definitive Agreement to be Acquired by Kuva Labs, Inc. - GlobeNewswire","headline":"Lisata Therapeutics Enters into Definitive Agreement to be Acquired by Kuva Labs, Inc.","sentiment":"neutral"},{"url":"https://news.google.com/rss/articles/CBMimgFBVV95cUxPQ1lTM3VNYXlucGd3T0trMkFRY0pwVDRVTkgwYzlvdFpoekVzbXZ4NElOZEs5RmkzYktBSkYyMlYzLTdabDlMNmRyVFJNeGZ1Y3c1MHFqWElMUHRiWU85c1Rid0l0MTlhTXVrcXRYV1ZGSm85OG1nX3pYQjFkRFhPcUtSYllUUEpzZW1rNlRUUHk5VE5BcjZkUW13?oc=5","date":"2026-01-27","type":"deal","source":"Yahoo Finance","summary":"Lisata Therapeutics Announces Mutual Termination of License Agreement with Qilu Pharmaceutical for Certepetide - Yahoo Finance","headline":"Lisata Therapeutics Announces Mutual Termination of License Agreement with Qilu Pharmaceutical for Certepetide","sentiment":"neutral"},{"url":"https://news.google.com/rss/articles/CBMiqgFBVV95cUxPTU5CMUxmWGtYMDhWVkF3WmRmb2ZWNlBfa1pwUGlsVlpmRnE5enBUakltaTNxQ0djaWdLLWdoeTZtWDdnY0VQNWMyT3B3Nzk3MXJ6TWVDQmVxRWhUYnpjUjJIYUlTTDEyQ0tMS0E2b1d4WGxKcGRSeVdkMWFiYWs3NGZXQVVuNC1TNVplOUFzVWh2M043cXdUQXBmLXJHNjFTdjVRNzNXVElDQQ?oc=5","date":"2026-01-27","type":"pipeline","source":"Fierce Biotech","summary":"Lisata reclaims China rights to solid tumor candidate ahead of acquisition - Fierce Biotech","headline":"Lisata reclaims China rights to solid tumor candidate ahead of acquisition","sentiment":"neutral"},{"url":"https://news.google.com/rss/articles/CBMizgFBVV95cUxNT3ZMUmFBeTZCMmdVLVFlNWNtMDFFN1FOWjhuMDlfYkVGQ0pkZ2YwbTIyNzltRkNtcVBnLVE0SEpYZ3Z0UVRwVDllWUowdHRxQkNVZkRaVlRzbjE2dWo4eHBhaGhXczM2MG1hSnI3M044VGFzYXU0TmVBLV9Pa0paSDFDNnM1cnZNQURGOE0xMHNWU0l6MHp6NmY5SnlwaDVGWGlDY3gtTV8zRENFNVJkSTdBaFRqdzJnUl9xaHROa19lQlBhWHRvN2ZXUFoyQQ?oc=5","date":"2026-01-27","type":"deal","source":"Investing.com","summary":"Lisata Therapeutics and Qilu Pharmaceutical end certepetide license agreement - Investing.com","headline":"Lisata Therapeutics and Qilu Pharmaceutical end certepetide license agreement","sentiment":"neutral"},{"url":"https://news.google.com/rss/articles/CBMitAFBVV95cUxQNVd3VFBwZGVyS0xCYkpnZzFFR1Y1REVBSXBGRVZLMDU0dlRmWEwweVRaVXlSSkhYTFVVSUhwV1dTZnRjZlo5cnE3emY4TTBEblNtMlhTZE03TlRyaWlETDh1Q1lLZXZmX0tYYlA1SlVaczRIUFBxSE0zajZYRmhlTmx6Y2NFZW9fbXlEeThMMVZ4X3JlSmgweHFscHUtS21ZdGpIUmlBWEQ1aTR2aFdacmx5b0c?oc=5","date":"2026-01-27","type":"pipeline","source":"Stock Titan","summary":"Cancer drug rights shift: Lisata takes back certepetide in China - Stock Titan","headline":"Cancer drug rights shift: Lisata takes back certepetide in China","sentiment":"neutral"},{"url":"https://news.google.com/rss/articles/CBMihgFBVV95cUxNMmV6Z3YyTkZkVGJTTWFXQnJzeWVCZ2QwREVzdTdsLWktc3cyNEJDZkVsWEt0aXZjaG9xMkxJcEtJWXV6dUlPY1N0Tml6Rkpwal9PYXNyZkVuM1owRXpnWHpLaDNoMUdOS3pMRGhrR3Q4dk1PQk1TaVRIMTBiVjMyTGFEcUoyZw?oc=5","date":"2026-01-22","type":"pipeline","source":"Yahoo Finance","summary":"Lisata Therapeutics And 2 Other Penny Stocks Worth Watching - Yahoo Finance","headline":"Lisata Therapeutics And 2 Other Penny Stocks Worth Watching","sentiment":"neutral"},{"url":"https://news.google.com/rss/articles/CBMiqAFBVV95cUxOam1ERFVaMS1JemRLU290VUxla1Z5VnprNTBTbWE4QnBjYWhGQ0dKU0JnZFBSWERRa3E4UlJtT2g2S25nUUNGWHZ0eEx3d0EyMTJLOXJKZXN2ZUNMcThJS0wyRVR6aGJ5TTF6OHhrU3h2LU9vcktENkJnSUF3dTdtamxKQV95QTN3VmN4OTRFY2tsRHI0c3JvN2RQWXVtR3dqc0ZfVjIxalY?oc=5","date":"2026-01-21","type":"deal","source":"citybiz","summary":"Lisata Therapeutics to be Acquired by Kuva Labs for $4.00 Per Share - citybiz","headline":"Lisata Therapeutics to be Acquired by Kuva Labs for $4.00 Per Share","sentiment":"neutral"},{"url":"https://news.google.com/rss/articles/CBMimAJBVV95cUxPT1BRT0NLNE9XZHdHTm9xcmF6ang0aVozVjRyOGlJZ3FXNzJrRE1vQW5raDZzaElvTzFxWTJMYU1QNk5mbEFqR2FkQXVJQjZLSDJPeWR3cDdNRVAtOXJ6YjlGRURiZUROeWdUeDFFMl80LWtGWWZINDVvS2VoSk5YejFIeVJuR0dDejVEN21iRVEwTDhEQU9mTXBDd1lwVHFaNmhkMGkwR0tBclV0Z1F3X2FXcVdWQ29fdmdGRWZsTUdNOF95c0U0RUgyRThVUkpuQ212X1dfWWZPNlRWajhXZDhNZFlsdUV3R202VTdZY1RETmphTmNfOHdKZno2T1BjZzdtZFEzQXQxV2dELVgxRnA5NTFCbkhG?oc=5","date":"2026-01-21","type":"deal","source":"GlobeNewswire","summary":"Lisata Therapeutics Enters Into Term Sheet to be Acquired - GlobeNewswire","headline":"Lisata Therapeutics Enters Into Term Sheet to be Acquired","sentiment":"neutral"},{"url":"https://news.google.com/rss/articles/CBMitgFBVV95cUxPSzlyN1BYQXhrM0REVFdlX0lkZnhfRE1GX1VsYXl3dzZIaFVHM2tnaXdad2IyclVveDM0dkZnR0hfV2tYbE5Mb2pSSy1hb2tiLXl0b21NX25OT3V6aGlrS0d3a3FjT0RkdW41Y2liRF9vTXR5ZzZmWjZYZ3BOaTA4R2g1ZkhmbkZCS0JOMTRJUEFYNmotUXZpYkkzRGFQbWxQU2tBRm45WmJMalhoZjN1cEdCbGgtdw?oc=5","date":"2025-06-11","type":"pipeline","source":"Stock Titan","summary":"Lisata CEO to Reveal Latest Cancer Treatment Developments at Major Biotech Conference - Stock Titan","headline":"Lisata CEO to Reveal Latest Cancer Treatment Developments at Major Biotech Conference","sentiment":"neutral"},{"url":"https://news.google.com/rss/articles/CBMiU0FVX3lxTE81MVlTN25KbEZydEQxV2poX1VXYzk2OExHU0tJYlE4N0M4aEd0cm93ek04WFVRV3pJWjZiZ1FrcExQbWt6emtEUDcwZ1FKdHpRcUJR?oc=5","date":"2025-04-24","type":"pipeline","source":"Stock Titan","summary":"LSTA Stock Price, News & Analysis - Stock Titan","headline":"LSTA Stock Price, News & Analysis","sentiment":"neutral"},{"url":"https://news.google.com/rss/articles/CBMi1gFBVV95cUxQYVRZYzN6OVgyZ2NCUm9jZTZEQUp4SlB5emVEb3lsRXVoeVd5SE5jdFYzbjJhazdVMmpvSHYtMEU0NUY2Ml9kRldNUVhGcmtUaTBXMzNrS2FuOGR3bVd5TUJxSTFXWE5XSzN4LVNxTi1DaURZMGRZVzNQMi1HbDB6MTBVdlA1T2tCMWt3Zkk0ZXBZNlI3TzVLSzdUc1R6ZG9hekpkcU5zNlJQcW80MzJyS1lOeFhrZ2RiaUM4eEcyZXNmaWo4Z2VwRkpWeGxMb19JOW5QUm1B?oc=5","date":"2024-06-14","type":"pipeline","source":"Proactive financial news","summary":"Lisata Therapeutics is pioneering new treatments for solid tumors - Proactive financial news","headline":"Lisata Therapeutics is pioneering new treatments for solid tumors","sentiment":"neutral"},{"url":"https://news.google.com/rss/articles/CBMiXEFVX3lxTE51MUNrQ0syR2I2dW44RzMwcGdTaUF4TGZGNDAwZm96VkJWYlhVOWw3Zmt4WW4wRW9QSDh5OFRvZ0RpdWxmWF92d2xIZTVHX3g5TnBjNzBpUzhvWTNF?oc=5","date":"2022-09-15","type":"pipeline","source":"TradingView","summary":"LSTA Stock Price and Chart — NASDAQ:LSTA - TradingView","headline":"LSTA Stock Price and Chart — NASDAQ:LSTA","sentiment":"neutral"}],"patents":[],"drugCount":3,"phaseCounts":{"phase_3":1,"phase_2":2},"enrichmentLevel":0,"visitCount":1,"keyCompetitors":[],"therapeuticFocus":[],"financials":null,"yahoo":null}